Marksans Pharma Limited — Others, 16-07-2025: Shareholders meeting

Marksans Pharma will hold its 33rd Annual General Meeting virtually on August 8. Shareholders will consider the adoption of financial results for FY25 and a proposed dividend of H 0.80 per share. Key agenda items include the re-appointment of Mrs. Sandra Saldanha and the appointment of Mr. Srinivas Mishra as an Independent Director. The company also seeks approvals to broaden its Employee Stock Option Scheme to include subsidiary employees, allowing grants within the 23 lakh options ceiling. This move aims to enhance group-wide employee motivation and retention.